Managing antimicrobial resistance in intensive care units

Critical Care Medicine
Tejal N GandhiLaraine L Washer

Abstract

The challenges in managing patients with infection in the intensive care unit are increased in an era where there are dwindling antimicrobial choices for multidrug-resistant pathogens. Clinicians in the intensive care unit must balance between choosing appropriate antimicrobial treatment for patients with suspected infection and utilizing antimicrobials in a judicious fashion. Improving antimicrobial utilization is a critical component to reducing antimicrobial resistance. Although providing effective antimicrobial therapy and improving antimicrobial utilization may seem to be competing goals, there are effective strategies to accomplish both. Antimicrobial stewardship programs provide an organized way to implement these strategies and can enhance the intensive care unit physician's success in improving patient outcomes and combating antimicrobial resistance in the intensive care unit.

References

Jul 13, 1970·JAMA : the Journal of the American Medical Association·W E Scheckler, J V Bennett
Jul 1, 1994·Journal of Clinical Microbiology·G V DoernB Levy
May 1, 1993·Antimicrobial Agents and Chemotherapy·A ForrestJ J Schentag
Nov 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J QualeK Patel
Feb 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L ArchibaldR Gaynes
May 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T C BaileyW C Dunagan
Apr 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M P WeinsteinL B Reller
Aug 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A C WhiteS B Greenberg
Jan 9, 1998·Infectious Disease Clinics of North America·R Gaynes
Jan 24, 1998·JAMA : the Journal of the American Medical Association·S L PrestonM Corrado
Feb 26, 1998·American Journal of Respiratory and Critical Care Medicine·J L TrouilletC Gibert
Mar 21, 1998·Archives of Internal Medicine·V StosorG A Noskin
Oct 24, 1998·JAMA : the Journal of the American Medical Association·J J RahalM Lim
Dec 10, 1998·Journal of Internal Medicine·L LeiboviciS D Pitlik
May 21, 1999·Archives of Internal Medicine·Y CarmeliM H Samore
Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D LandmanJ M Quale
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S K FridkinF C Tenover
Oct 26, 2000·Current Opinion in Microbiology·S Monroe, R Polk
Jan 5, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lorraine KyneCiarán P Kelly
Dec 12, 2002·Chest·Jordi RelloUNKNOWN VAP Outcomes Scientific Advisory Group
Dec 20, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E CosgroveYehuda Carmeli
Jan 25, 2003·Critical Care Medicine·David L Paterson
Feb 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ebbing LautenbachNeil O Fishman
Feb 18, 2003·JAMA : the Journal of the American Medical Association·Melinda M NeuhauserJohn P Quinn
Apr 10, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David L Paterson, Louis B Rice
Jun 20, 2003·Lancet·Jean-Louis Vincent
Jul 12, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carlos BantarMaría Eugenia Oliva
Sep 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lala M DunbarJames B Kahn
Sep 27, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Philip CarlingMichael Barza
Nov 20, 2003·JAMA : the Journal of the American Medical Association·Jean ChastreUNKNOWN PneumA Trial Group

❮ Previous
Next ❯

Citations

Jan 25, 2013·Molecular Diagnosis & Therapy·Lesley J Scott
Aug 4, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher A Ohl, Elizabeth S Dodds Ashley
Nov 16, 2012·The Journal of Antimicrobial Chemotherapy·Jonathan Cohen
May 10, 2011·FEBS Letters·Jean-Michel BollaJean-Marie Pagès
Jul 29, 2011·Pharmacoepidemiology and Drug Safety·Ria BenkoEdit Hajdú
Mar 16, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·John E McGowan
Apr 5, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jason M PogueDaryl D DePestel
Aug 21, 2015·Intensive Care Medicine·J J De WaeleG Dimopoulos
Jun 29, 2011·FEMS Microbiology Reviews·Hiroshi Nikaido, Jean-Marie Pagès
Nov 3, 2016·Expert Opinion on Drug Metabolism & Toxicology·Sandrine AlibertJean-Marie Pagès
Sep 6, 2014·Bioconjugate Chemistry·Anas AllamIsabelle Artaud
Jun 21, 2011·Critical Care Medicine·Maria E JohansenJens D Lundgren
Aug 16, 2011·Dimensions of Critical Care Nursing : DCCN·Robert W HutchisonG Mark Montgomery
Aug 5, 2010·Critical Care Medicine·Jan E PattersonLisa L Maragakis
Jun 8, 2018·The Journal of Antimicrobial Chemotherapy·Annelie A MonnierUNKNOWN DRIVE-AB WP1 group
Mar 24, 2020·Disease-a-month : DM·Manar Ali AbushaheenPoojdev Jhugroo
Jun 6, 2014·ACS Medicinal Chemistry Letters·Jean-Marie PagèsIsabelle Artaud
Nov 14, 2012·Journal of the American Chemical Society·Francesca ColluPaolo Ruggerone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.